Stockscreener 앱 받기
8.27
0.72%
-0.06
전일 마감가:
$8.33
열려 있는:
$8.47
하루 거래량:
1.38M
Relative Volume:
0.98
시가총액:
$1.22B
수익:
$177.28M
순이익/손실:
$-195.24M
주가수익비율:
-6.1716
EPS:
-1.34
순현금흐름:
$-114.54M
1주 성능:
-0.72%
1개월 성능:
+11.01%
6개월 성능:
+79.39%
1년 성능:
+116.49%
1일 변동 폭
$8.09
$8.62
1주일 범위
$8.09
$8.95
52주 변동 폭
$2.28
$8.95
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
ADPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
8.27 | 1.22B | 177.28M | -195.24M | -114.54M | -1.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Cathie Wood’s Ark Invest Makes Bold Moves: Buys BEAM & NU, Sells MELI & ADPT - Apna Kal
Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies - Benzinga India
Adaptive Biotechnologies CEO Chad Robins sells over $2.4m in stock - Investing.com Nigeria
Cathie Wood's ARK buys Beam Therapeutics, sells Adaptive Biotech stock By Investing.com - Investing.com Australia
Cathie Wood's ARK buys Beam Therapeutics, sells Adaptive Biotech stock - Investing.com India
Adaptive Biotechnologies CEO Chad Robins sells $3.99 million in shares By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CEO Chad Robins sells $3.99 million in shares - Investing.com
Adaptive Biotechnologies CEO Chad M Robins Sells Over $3.9 Million in Company Stock - TradingView
ADPT stock soars to 52-week high, reaching $8.33 - MSN
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 7.9% Following Analyst Upgrade - Armenian Reporter
Scotiabank Forecasts Strong Price Appreciation for Adaptive Biotechnologies (NASDAQ:ADPT) Stock - Defense World
Legato Capital Management LLC Decreases Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 7.9% on Analyst Upgrade - MarketBeat
Scotiabank Issues Positive Forecast for Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price - MarketBeat
Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank - Yahoo Finance
Adaptive Biotechnologies targets $1,300 ASP for MRD tests in 2025 driven by pricing improvements - MSN
Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates - MSN
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year High After Analyst Upgrade - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Down 5.2%Time to Sell? - MarketBeat
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2024 Earnings Call Transcript - Insider Monkey
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ... By GuruFocus - Investing.com Canada
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highl - GuruFocus.com
Adaptive Biotechnologies: Q4 Earnings Snapshot - The Advocate
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ... - Yahoo Finance
Adaptive Biotechnologies Q4 revenue beats estimates, loss narrower than expected - Investing.com
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings: EPS of -$ - GuruFocus.com
Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Adaptive Biotechnologies earnings beat by $0.02, revenue topped estimates - Investing.com
Adaptive Biotechnologies' Q4 Loss Narrows, Revenue Rises -February 11, 2025 at 05:12 pm EST - Marketscreener.com
Adaptive Biotechnologies: Q4 Earnings Snapshot -February 11, 2025 at 04:46 pm EST - Marketscreener.com
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Earnings Flash (ADPT) Adaptive Biotechnologies Reports Q4 Revenue $47.5M, vs. FactSet Est of $46.0M - Marketscreener.com
Adaptive's MRD Division Hits Record Growth: Medicare Boosts Test Rates 17% as Volume Soars - StockTitan
Earnings Scheduled For February 11, 2025 - Benzinga
Gaining Ground: Adaptive Biotechnologies Corp (ADPT) Closes Lower at 7.84, Down -2.12 - The Dwinnex
Adaptive Biotechnologies (ADPT) to Release Earnings on Tuesday - Defense World
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Report Pre - GuruFocus.com
Gaining Ground: Hepion Pharmaceuticals Inc (HEPA) Closes Higher at 0.17, Up 3.43 - The Dwinnex
Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 9.8%What's Next? - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Down 4.6%Should You Sell? - MarketBeat
It makes sense and dollars to buy Adaptive Biotechnologies Corp (ADPT) stock - SETE News
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - Yahoo Finance
Analysts review Adaptive Biotechnologies Corp’s rating - Knox Daily
Adaptive Biotechnologies Corp (ADPT) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Sumitomo Mitsui Trust Group, Inc. Reduces Stake in Adaptive Biot - GuruFocus.com
Stock Performance Spotlight: Adaptive Biotechnologies Corp (ADPT) Ends the Day at 7.70, Down by -0.65 - The Dwinnex
How did Adaptive Biotechnologies Corp (ADPT) fare last session? - US Post News
Adaptive Biotechnologies (ADPT) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
The Goldman Sachs Group Forecasts Strong Price Appreciation for Adaptive Biotechnologies (NASDAQ:ADPT) Stock - MarketBeat
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adaptive Biotechnologies Corp 주식 (ADPT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M | CEO and Chairman |
Feb 20 '25 |
Option Exercise |
6.32 |
99,107 |
626,356 |
2,675,808 |
| ROBINS CHAD M | CEO and Chairman |
Feb 19 '25 |
Sale |
8.46 |
186,080 |
1,574,237 |
2,576,701 |
| ROBINS CHAD M | CEO and Chairman |
Feb 20 '25 |
Sale |
8.44 |
99,107 |
836,463 |
2,576,701 |
0.27%
3.05%
자본화:
|
볼륨(24시간):